Shahedur Rahman
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Shahedur Rahman's research focuses on the development of nanomedicines for cancer therapy. His work, including a 2026 publication, investigates the use of macrocyclic histone deacetylase inhibitors integrated into near-infrared-responsive ionic nanomedicines. This approach aims to enhance the efficacy of cancer treatments by leveraging targeted drug delivery and response to external stimuli. Rahman collaborates with researchers at the University of Arkansas at Little Rock, including Nawab Ali, Monowar Hossain, and Adeolu Oluremi, as well as Mahfuzul Hassan from Philander Smith College, with whom he has co-authored publications. His scholarly output to date includes one publication.
Metrics
- Publications: 1
Selected Publications
-
Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy (2026)
Collaboration Network
Top Collaborators
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
- Macrocyclic histone deacetylase inhibitor-based near-infrared-responsive ionic nanomedicines for enhanced cancer therapy
Similar Researchers
Based on overlapping research topics